Cholinergic and alpha-adrenergic stimulation of prostaglandin release by dog thyroid in vitro

Endocrinology. 1979 Oct;105(4):988-95. doi: 10.1210/endo-105-4-988.

Abstract

Dog thyroid slices released in their incubation medium prostaglandins E2 (PGE2), F2 alpha (PGF2 alpha), 15-keto-13,14-dihydro-F2 alpha, and thromboxane B2 (TxB2), as measured by direct RIA. This release could be inhibited by indomethacin and naproxen, indicating that it corresponded to a neosynthesis. Carbamylcholine (2--100 microns) stimulated the release of PGE2, PGF2 alpha, and TxB2, whereas epinephrine (20 microns to 1 nM) enhanced the release of PGE2 and PGF2 alpha but had no effect on TxB2. These stimulations were inhibited by atropine and dihydroergocryptine, respectively, suggesting that a muscarinic and an alpha-adrenergic receptor were involved. The ionophore A23187 reproduced these stimulations, and the stimulatory effects of carbamylcholine and epinephrine were inhibited in the absence of exogenous Ca++ and after EGTA depletion. Ca++ thus appears as a major regulator of PG production in the thyroid. TSH (0.06--10 MU/ml) and dibutyryl cAMP had no effect on the release of PGE2, PGF2 alpha, or TxB2 by dog thyroid in vitro.

MeSH terms

  • Animals
  • Atropine / pharmacology
  • Calcimycin / pharmacology
  • Carbachol / pharmacology*
  • Dogs
  • Dose-Response Relationship, Drug
  • Epinephrine / pharmacology*
  • In Vitro Techniques
  • Indomethacin / pharmacology*
  • Naproxen / pharmacology*
  • Prostaglandins / metabolism*
  • Prostaglandins F / metabolism
  • Radioimmunoassay
  • Thyroid Gland / drug effects
  • Thyroid Gland / metabolism*

Substances

  • Prostaglandins
  • Prostaglandins F
  • Calcimycin
  • Naproxen
  • Atropine
  • Carbachol
  • Indomethacin
  • Epinephrine